Cargando…
Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story?
INTRODUCTION: COVID-19 has caused approximately one million deaths worldwide as of November 24, 2020. Markers of disease activity like ferritin, C-reactive protein (CRP), and D-dimers are frequently monitored to detect the best opportunity for intensive treatment. METHODS: All patients of >18 yea...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089454/ http://dx.doi.org/10.1159/000514406 |
_version_ | 1783687043436511232 |
---|---|
author | Nadeem, Rashid Elhoufi, Ashraf Mahmoud Iqbal, Naheed Elahi Obaida, Zainab Abdulameer Elgohary, Doaa Mohamed Singh, Mukesh Kumar Zoraey, Shymaa Farouk Abdalla, Rami M. Eltayeb, Sara Yousif Danthi, Crystal Sharon Azaza, Nouha Ahmed, Waleed Mohamed Hafeez, Muzammil AlSada, Maryam Mir, Fatima Farid |
author_facet | Nadeem, Rashid Elhoufi, Ashraf Mahmoud Iqbal, Naheed Elahi Obaida, Zainab Abdulameer Elgohary, Doaa Mohamed Singh, Mukesh Kumar Zoraey, Shymaa Farouk Abdalla, Rami M. Eltayeb, Sara Yousif Danthi, Crystal Sharon Azaza, Nouha Ahmed, Waleed Mohamed Hafeez, Muzammil AlSada, Maryam Mir, Fatima Farid |
author_sort | Nadeem, Rashid |
collection | PubMed |
description | INTRODUCTION: COVID-19 has caused approximately one million deaths worldwide as of November 24, 2020. Markers of disease activity like ferritin, C-reactive protein (CRP), and D-dimers are frequently monitored to detect the best opportunity for intensive treatment. METHODS: All patients of >18 years of age were included. The primary variables of interest, ferritin, CRP, and D-dimers, for each patient throughout hospitalization were recorded. Primary clinical outcomes of length of stay in ICU and survival were recorded. DEMOGRAPHICS: age, gender, BMI, and nationality. Ferritin, CRP, and D-dimers were recorded daily if available for the whole ICU stay, and all other variables were recorded on admission day to ICU. RESULTS: The sample includes 235 records. More than 95% of patients have all markers on the day of admission to ICU were ferritin (median 1,278; IQR 1,424), D-dimer 1.21 (3.4), and CRP 129.5 (121). Daily average levels of markers were different from their admission day level: ferritin 1,395 (1,331), D-dimer 3.11 (5.52), and CRP 107 (75.8). Multiple logistic regression analysis determined that average CRP during the stay was the only predictor of survival. DISCUSSION: Data on markers utilization to detect the acute phase of inflammation help clinicians focus on the opportunity window for intensive treatment. CONCLUSION: Average CRP during the stay in ICU is higher than CRP on admission. Average CRP is the only factor that predicts survival. |
format | Online Article Text |
id | pubmed-8089454 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-80894542021-05-03 Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story? Nadeem, Rashid Elhoufi, Ashraf Mahmoud Iqbal, Naheed Elahi Obaida, Zainab Abdulameer Elgohary, Doaa Mohamed Singh, Mukesh Kumar Zoraey, Shymaa Farouk Abdalla, Rami M. Eltayeb, Sara Yousif Danthi, Crystal Sharon Azaza, Nouha Ahmed, Waleed Mohamed Hafeez, Muzammil AlSada, Maryam Mir, Fatima Farid Dubai Medical Journal Educational Corner − Research Article INTRODUCTION: COVID-19 has caused approximately one million deaths worldwide as of November 24, 2020. Markers of disease activity like ferritin, C-reactive protein (CRP), and D-dimers are frequently monitored to detect the best opportunity for intensive treatment. METHODS: All patients of >18 years of age were included. The primary variables of interest, ferritin, CRP, and D-dimers, for each patient throughout hospitalization were recorded. Primary clinical outcomes of length of stay in ICU and survival were recorded. DEMOGRAPHICS: age, gender, BMI, and nationality. Ferritin, CRP, and D-dimers were recorded daily if available for the whole ICU stay, and all other variables were recorded on admission day to ICU. RESULTS: The sample includes 235 records. More than 95% of patients have all markers on the day of admission to ICU were ferritin (median 1,278; IQR 1,424), D-dimer 1.21 (3.4), and CRP 129.5 (121). Daily average levels of markers were different from their admission day level: ferritin 1,395 (1,331), D-dimer 3.11 (5.52), and CRP 107 (75.8). Multiple logistic regression analysis determined that average CRP during the stay was the only predictor of survival. DISCUSSION: Data on markers utilization to detect the acute phase of inflammation help clinicians focus on the opportunity window for intensive treatment. CONCLUSION: Average CRP during the stay in ICU is higher than CRP on admission. Average CRP is the only factor that predicts survival. S. Karger AG 2021-04-14 /pmc/articles/PMC8089454/ http://dx.doi.org/10.1159/000514406 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc-nd/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. |
spellingShingle | Educational Corner − Research Article Nadeem, Rashid Elhoufi, Ashraf Mahmoud Iqbal, Naheed Elahi Obaida, Zainab Abdulameer Elgohary, Doaa Mohamed Singh, Mukesh Kumar Zoraey, Shymaa Farouk Abdalla, Rami M. Eltayeb, Sara Yousif Danthi, Crystal Sharon Azaza, Nouha Ahmed, Waleed Mohamed Hafeez, Muzammil AlSada, Maryam Mir, Fatima Farid Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story? |
title | Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story? |
title_full | Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story? |
title_fullStr | Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story? |
title_full_unstemmed | Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story? |
title_short | Prediction of Cytokine Storm and Mortality in Patients with COVID-19 Admitted to ICU: Do Markers Tell the Story? |
title_sort | prediction of cytokine storm and mortality in patients with covid-19 admitted to icu: do markers tell the story? |
topic | Educational Corner − Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089454/ http://dx.doi.org/10.1159/000514406 |
work_keys_str_mv | AT nadeemrashid predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory AT elhoufiashrafmahmoud predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory AT iqbalnaheedelahi predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory AT obaidazainababdulameer predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory AT elgoharydoaamohamed predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory AT singhmukeshkumar predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory AT zoraeyshymaafarouk predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory AT abdallaramim predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory AT eltayebsarayousif predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory AT danthicrystalsharon predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory AT azazanouha predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory AT ahmedwaleedmohamed predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory AT hafeezmuzammil predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory AT alsadamaryam predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory AT mirfatimafarid predictionofcytokinestormandmortalityinpatientswithcovid19admittedtoicudomarkerstellthestory |